This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 632602
Submitted by lobbyist on: March 20, 2017 03:12:21 PM
Accepted by Registrar on: March 20, 2017 03:27:48 PM
Designated Filer Information
Dawson, Robert W |
17300 Trans-Canada Highway | |
Kirkland, QC, H9J 2M5
|
250-472-7601 |
Canada |
Organization Information
Pfizer |
Pfizer Inc. is a world leading research based pharmaceutical company. Pfizer discovers and develops life-saving and life-enhancing medications and vaccines for humans. We also provide cost-saving off-patented medicines and biosimilars. The Canadian operation is one of the largest private contributors to health research in Canada and also donates millions of dollars annually to support community initiatives. |
17300 Trans-Canada Highway | |
Kirkland, QC, H9J 2M5
|
250-472-7601 |
Canada |
Relevant Affiliates
Type:
Business Name | Mailing Address | Contact Information |
---|---|---|
Pfizer Inc. |
235 East 42nd Street
New York, NY 10017 United States of America |
Phone: 514-426-6888 |
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
March 20, 2017 | |
September 16, 2017 |
Organization's In-House Lobbyists
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Economic Development and Trade
Arranging meeting between an individual and a public office holder for purpose of lobbying
Meeting with the Minister of Jobs, Trade and Technology to discuss Pfizer investment opportunity ideas in job creation, economic diversification, education and training.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Minister | Ralston, Bruce | Minister of Jobs, Trade and Technology | August 4, 2017 |
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Meeting with the Minister of Health to discuss the need for evidence base adoption mechanisms that integrates patients, health care professionals, manufacturers and government perspectives in pharmaceutical policy implementation.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Minister | Dix, Adrian | Minister of Health | August 4, 2017 |
Public Agency | Provincial Health Services Authority | March 20, 2017 |